February 26, Appendix 4D & Half Year Report
210226_Appendix 4D, half yearly report
February 15, Canine Monepantel Phase IIb Lymphoma Trial Update
210215_PhaseIIb_update
February 10, LUMC Covid-19 Research Update
210210_LUMC_Update
January 31, Top 20 Shareholders
210131_Top20Shareholders
January 27, Appendix 4C and Quarterly Update
210127_Appendix 4C and Quarterly Update
January 22, Epichem Awarded $200k e-Waste Grant
210122_Epichem Award
January 9, PAA LUMC COVID-19 Research Update
210109_PAA_LUMC Update
December 31, Top 20 Shareholders
201231_Top_Holders_Report (91)
December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials
201223_PAA_Syngene_FightMND_Manufacture
December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial
201222_PhaseIIbcaninetrial